What is Microtrace?
Microtrace operates as a premier materials analysis laboratory, renowned for its expertise in identifying and characterizing microscopic quantities of unknown substances. Leveraging advanced microscopy and microchemical methodologies, the company offers critical analytical support across a spectrum of sectors. These include legal proceedings for criminal and civil litigation, as well as specialized services for industries such as pharmaceuticals, food safety, environmental monitoring, and manufacturing. Their capabilities extend to intricate analyses like forensic art examination, contaminant identification, and consumer complaint resolution. With a legacy spanning over three decades, Microtrace has cultivated an international reputation for its unwavering commitment to quality and its scientifically rigorous approach to resolving complex analytical challenges.
How much funding has Microtrace raised?
Microtrace has raised a total of $348K across 2 funding rounds:
Debt
$150K
Debt
$198K
Debt (2020): $150K with participation from PPP
Debt (2021): $198K led by PPP
Key Investors in Microtrace
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for Microtrace?
The substantial backing, indicated by the $348K in total capital raised and the recent $198K strategic investment, positions Microtrace for continued expansion and technological advancement. As a company operating in a late-stage funding environment, this capital infusion is likely to fuel further development of its analytical capabilities, enhance its service offerings, and potentially broaden its market reach. The strategic nature of the recent financing suggests a focus on strengthening its competitive advantage and solidifying its leadership in the niche field of micro-particle analysis, enabling Microtrace to tackle increasingly complex scientific and forensic challenges.
See full Microtrace company page
